Mantle cell lymphoma strategies in primary treatment

Research output: ThesisDoctoral Thesis (compilation)

More filtering options
  1. 2016
  2. Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4

    Alexandra Albertsson-Lindblad, Kolstad, A., Laurell, A., Räty, R., Grønbæk, K., Sundberg, J., Pedersen, L. B., Ralfkiær, E., Karjalainen-Lindsberg, M-L., Sundström, C., Mats Ehinger, Geisler, C. & Mats Jerkeman, 2016 Jun 27, In : Blood. 128, 14, p. 1814-1820

    Research output: Contribution to journalArticle

  3. 2014
  4. Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.

    Abrahamsson, A., Alexandra Albertsson Lindblad, Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M., D'Amore, F., Nilsson-Ehle, H., Jensen, P., Pedersen, M., Geisler, C. H. & Mats Jerkeman, 2014, In : Blood. 124, 8, p. 1288-1295

    Research output: Contribution to journalArticle